Cardiac Assist Devices (CAD) Global Market-Forecast to 2024

Publishing Date : January, 2018
Report Code : HCMD0155
Price:
Single license $4,950
Site license $6,750
Global license $9,000


The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The Cardiac assist devices (CAD) i.e. VAD, TAH and IABP are used to treat various conditions related to heart such as end stage heart failure, refractory angina pectoris, post-cardiopulmonary bypass shock, myocardial infarction, myocarditis, etc. The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body. The indication for VAD use is acute cardiogenic shock (post cardiac surgery, myocarditis and massive myocardial infarction) and chronic heart failure. An artificial heart (TAH) is a mechanical assist device for persons with biventricular heart failure and heart transplant candidate which replaces both native ventricles and all four chambers of heart, thereby eliminating the symptoms of cardiac insufficiency or heart failure. Intra-aortic balloon pump (IABP) is placed in aorta to help the heart to pump more blood by reducing the workload on the heart and improves the function of the left ventricle as this is the chamber that pumps blood into the aorta. IABP is used in conditions such as acute mitral valve regurgitation or severe heart failure, left ventricular failure, unstable angina, etc.

According to IQ4I Analysis, Cardiac assist devices global market is expected to grow at a double digit CAGR to reach $4,255.5 million by 2024. Products of Cardiac assist devices market is segmented into Ventricular Assist Device {(Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD)}, Total Artificial Heart (TAH) and Intra-Aortic Balloon Pump (IABP). CAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. CAD market by implant type is segmented into Extracorporeal CAD, Intracorporeal CAD and Percutaneous CAD. CAD market by patient type is segmented into Adult and Pediatric CAD. Applications of Cardiac assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR). End-User of Cardiac assist devices are segmented into hospitals, academics & research institutes and other End-user (catheterization labs and ambulatory settings).

This report concentrates on Cardiac assist devices that are placed internally (VAD, TAH), externally (VAD) and percutaneously (VAD and IABP) for treating end-stage heart failure, cardiogenic shock, ventricular insufficiency, acute heart attack, intraoperative and postoperative cardiac procedures. The mechanical circulatory devices like extracorporeal membrane oxygenation (ECMO) or Heart lung machine and other cardiac assist devices like pacemakers and defibrillators are not considered in Cardiac assist devices global market report.

Some of the key players of the Cardiac assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Reliant Heart (U.S.), Fresenius Medical Care AG & Co. KGaA Care AG & Co. KGaA (Germany), Getinge Group (Sweden), Syncardia Systems, Inc  (U.S.), Zeon Corporation (Japan), Teleflex Incorporated (U.S.), etc.

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASING INCIDENCE OF HEART FAILURE
        • 3.3.1.2     SHORTAGE OF HEART DONORS
        • 3.3.1.3     TECHNOLOGICAL ADVANCEMENTS IN VAD
        • 3.3.1.4     RISING GERIATRIC POPULATION
        • 3.3.1.5     VAST PIPELINE PRODUCTS
        • 3.3.1.6     INCREASE IN FUNDING FOR CAD RESEARCH
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     ADVERSE EVENTS AND COMPLICATION WITH THE IMPLANTATIONS OF CAD
        • 3.3.2.2     COST OF THE DEVICES
        • 3.3.2.3     LACK OF SKILLED AND TRAINED PROFESSIONALS
        • 3.3.2.4     STRINGENT REGULATORY GUIDELINES
        • 3.3.2.5     AVAILABILITY OF ALTERNATIVE PRODUCTS
        • 3.3.2.6     CARDIAC ASSIST DEVICES PRODUCT RECALLS DUE TO FDA MANDATES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     CHINA
      • 3.4.6     JAPAN
      • 3.4.7     INDIA
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
        • 3.5.1.1     VENTRICULAR ASSIST DEVICE REIMBURSEMENT
        • 3.5.1.2     CAD PHYSICIAN REIMBURSEMENT
    • 3.6     UPCOMING TECHNOLOGY
    • 3.7     CLINICL TRIAL DATA
    • 3.8     PATENT TRENDS
    • 3.9     TECHNOLOGICAL ADVANCEMENTS
      • 3.9.1     INTRODUCTION
      • 3.9.2     PERCUTANEOUS VENTRICULAR ASSIST DEVICES (PVAD)
      • 3.9.3     MEDICAL COATINGS FOR CARDIAC ASSIST DEVICES
      • 3.9.4     ADVANCEMENT IN BLOOD FLOW TECHNOLOGY
    • 3.10     PORTER’S FIVE FORCE ANALYSIS
      • 3.10.1     THREAT OF NEW ENTRANTS
      • 3.10.2     THREAT OF SUBSTITUTES
      • 3.10.3     BARGAINING POWER OF SUPPLIERS
      • 3.10.4     BARGAINING POWER OF BUYERS
      • 3.10.5     COMPETITIVE RIVALRY
    • 3.11     SUPPLY CHAIN ANALYSIS
    • 3.12     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.12.1     CARDIAC ASSIST DEVICE GLOBAL MARKET SHARE ANALYSIS
      • 3.12.2     VENTRICULAR ASSIST DEVICE GLOBAL MARKET SHARE ANALYSIS
      • 3.12.3     INTRA-AORTIC BALLOON PUMP GLOBAL MARKET SHARE ANALYSIS
    • 3.13     CARDIAC ASSIST DEVICES NUMBER OF UNITS BY REGION
      • 3.13.1     VENTRICULAR ASSIST DEVICES NUMBER OF UNITS BY REGION
        • 3.13.1.1     EXTRACORPOREAL VENTRICULAR ASSIST DEVICES
        • 3.13.1.2     INTRACORPOREAL VENTRICULAR ASSIST DEVICES
        • 3.13.1.3     PERCUTANEOUS VENTRICULAR ASSIST DEVICES
      • 3.13.2     TOTAL ARTIFICIAL HEART NUMBER OF UNITS BY REGION
    • 3.14     COMPARISON OF CARDIAC ASSIST DEVICES
  • 4     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     VENTRICULAR ASSIST DEVICES (VAD)
      • 4.2.1     LEFT VENTRICULAR ASSIST DEVICES (LVAD)
      • 4.2.2     RIGHT VENTRICULAR ASSIST DEVICES (RVAD)
      • 4.2.3     BI-VENTRICULAR ASSIST DEVICES (BIVAD)
    • 4.3     INTRA-AORTIC BALLOON PUMPS (IABP)
    • 4.4     TOTAL ARTFICIAL HEART (TAH)
  • 5     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE
    • 5.1     INTRODUCTION
    • 5.2     EXTRACORPOREAL OR PARACORPOREAL CAD
    • 5.3     INTRACORPOREAL CAD
    • 5.4     PERCUTANEOUS CAD
  • 6     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE
    • 6.1     INTRODUCTION
    • 6.2     PULSATILE FLOW PUMP
    • 6.3     CONTINUOUS FLOW PUMP
      • 6.3.1     CENTRIFUGAL FLOW PUMP
      • 6.3.2     AXIAL FLOW PUMP
  • 7     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE
    • 7.1     INTRODUCTION
    • 7.2     PEDIATRIC CAD
    • 7.3     ADULT CAD
  • 8     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY APPLICATION
    • 8.1     INTRODUCTION
    • 8.2     BRIDGE TO TRANSPLANT (BTT)
    • 8.3     BRIDGE TO DESTINATION THERAPY (BTD)
    • 8.4     BRIDGE TO RECOVERY (BTR)
  • 9     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY END-USERS
    • 9.1     INTRODUCTION
    • 9.2     HOSPITALS
    • 9.3     ACADEMICS & RESEARCH INSTITUTES
    • 9.4     OTHER END-USERS
  • 10     REGIONAL ANALYSIS
    • 10.1     INTRODUCTION
    • 10.2     NORTH AMERICA
      • 10.2.1     U.S.
      • 10.2.2     OTHERS
    • 10.3     EUROPE
      • 10.3.1     GERMANY
      • 10.3.2     FRANCE
      • 10.3.3     U.K.
      • 10.3.4     OTHERS
    • 10.4     APAC
      • 10.4.1     JAPAN
      • 10.4.2     CHINA
      • 10.4.3     INDIA
      • 10.4.4     OTHERS
    • 10.5     ROW
      • 10.5.1     BRAZIL
      • 10.5.2     REST OF LATIN AMERICA
      • 10.5.3     MIDDLE EAST AND OTHERS
  • 11     COMPANY DEVELOPMENTS
    • 11.1     INTRODUCTION
    • 11.2     APPROVALS
    • 11.3     ACQUISITIONS
    • 11.4     PARTNERSHIPS
    • 11.5     OTHER DEVELOPMENTS
  • 12     MAJOR COMPANIES
    • 12.1     ABBOTT LABORATORIES
      • 12.1.1     OVERVIEW
      • 12.1.2     FINANCIALS
      • 12.1.3     PRODUCT PORTFOLIO
      • 12.1.4     KEY DEVELOPMENTS
      • 12.1.5     BUSINESS STRATEGY
      • 12.1.6     SWOT ANALYSIS
    • 12.2     ABIOMED, INC.
      • 12.2.1     OVERVIEW
      • 12.2.2     FINANCIALS
      • 12.2.3     PRODUCT PORTFOLIO
      • 12.2.4     KEY DEVELOPMENTS
      • 12.2.5     BUSINESS STRATEGY
      • 12.2.6     SWOT ANALYSIS
    • 12.3     BERLIN HEART GMBH
      • 12.3.1     OVERVIEW
      • 12.3.2     FINANCIALS
      • 12.3.3     PRODUCT PORTFOLIO
      • 12.3.4     KEY DEVELOPMENTS
      • 12.3.5     BUSINESS STRATEGY
      • 12.3.6     SWOT ANALYSIS
    • 12.4     BIVACOR INC.
      • 12.4.1     OVERVIEW
      • 12.4.2     FINANCIALS
      • 12.4.3     PRODUCT PORTFOLIO
      • 12.4.4     KEY DEVELOPMNTS
      • 12.4.5     BUSINESS STRATEGY
      • 12.4.6     SWOT ANALYSIS
    • 12.5     CARMAT SA
      • 12.5.1     OVERVIEW
      • 12.5.2     FINANCIALS
      • 12.5.3     PRODUCT PORTFOLIO
      • 12.5.4     KEY DEVELOPMNTS
      • 12.5.5     BUSINESS STRATEGY
      • 12.5.6     SWOT ANALYSIS
    • 12.6     FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
      • 12.6.1     OVERVIEW
      • 12.6.2     FINANCIALS
      • 12.6.3     PRODUCT PORTFOLIO
      • 12.6.4     KEY DEVELOPMNTS
      • 12.6.5     BUSINESS STRATEGY
      • 12.6.6     SWOT ANALYSIS
    • 12.7     GETINGE GROUP (MAQUET)
      • 12.7.1     OVERVIEW
      • 12.7.2     FINANCIALS
      • 12.7.3     PRODUCT PORTFOLIO
      • 12.7.4     KEY DEVELOPMENTS
      • 12.7.5     BUSINESS STRATEGY
      • 12.7.6     SWOT ANALYSIS
    • 12.8     MEDTRONIC, PLC
      • 12.8.1     OVERVIEW
      • 12.8.2     FINANCIALS
      • 12.8.3     PRODUCT PORTFOLIO
      • 12.8.4     KEY DEVELOPMENTS
      • 12.8.5     BUSINESS STRATEGY
      • 12.8.6     SWOT ANALYSIS
    • 12.9     RELIANTHEART INC.
      • 12.9.1     OVERVIEW
      • 12.9.2     FINANCIALS
      • 12.9.3     PRODUCT PORTFOLIO
      • 12.9.4     KEY DEVELOPMNTS
      • 12.9.5     BUSINESS STRATEGY
      • 12.9.6     SWOT ANALYSIS
    • 12.10     SYNCARDIA SYSTEMS, INC
      • 12.10.1     OVERVIEW
      • 12.10.2     FINANCIALS
      • 12.10.3     PRODUCT PORTFOLIO
      • 12.10.4     KEY DEVELOPMENTS
      • 12.10.5     BUSINESS STRATEGY
      • 12.10.6     SWOT ANALYSIS
    • 12.11     TELEFLEX INCORPORATED
      • 12.11.1     OVERVIEW
      • 12.11.2     FINANCIALS
      • 12.11.3     PRODUCT PORTFOLIO
      • 12.11.4     KEY DEVELOPMENTS
      • 12.11.5     BUSINESS STRATEGY
      • 12.11.6     SWOT ANALYSIS
    • 12.12     ZEON CORPORATION
      • 12.12.1     OVERVIEW
      • 12.12.2     FINANCIALS
      • 12.12.3     PRODUCT PORTFOLIO
      • 12.12.4     KEY DEVELOPMENTS
      • 12.12.5     BUSINESS STRATEGY
      • 12.12.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 2     EXTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 3     INTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 4     PERCUTANEOUS VAD NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 5     TOTAL ARTIFICIAL HEART NUMBER OF UNITS, BY REGION, (2016-2024) (NO’S)
      • TABLE 6     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
      • TABLE 7     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
      • TABLE 8     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 9     LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 10     RIGHT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 11     BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 12     INTRA-AORTIC BALLOON PUMP GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 13     TOTAL ARTIFICIAL HEART GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 14     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2016-2024) ($MN)
      • TABLE 15     EXTRACORPOREAL OR PARACORPOREAL CAD GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 16     INTRACORPOREAL CAD GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 17     PERCUTANEOUS CAD GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 18     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 19     PULSATILE FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 20     CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 21     CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 22     CENTRIFUGAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 23     AXIAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 24     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE, (2016-2024) ($MN)
      • TABLE 25     PEDIATRIC CAD GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 26     ADULT CAD GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 27     CARDIAC ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 28     BRIDGE TO TRANSPLANT GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 29     BRIDGE TO DESTINATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 30     BRIDGE TO RECOVERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 31     CARDIAC ASSIST DEVICE GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
      • TABLE 32     HOSPITAL GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 33     ACADEMICS & RESEARCH INSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 34     OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 35     CARDIAC ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN), CAGR (%)
      • TABLE 36     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 37     NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 38     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2016-2024) ($MN)
      • TABLE 39     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 40     NORTH AMERICA CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 41     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2016-2024) ($MN)
      • TABLE 42     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 43     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 44     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 45     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 46     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 47     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2016-2024) ($MN)
      • TABLE 48     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 49     EUROPE CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 50     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2016-2024) ($MN)
      • TABLE 51     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 52     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 53     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 54     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 55     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 56     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2016-2024) ($MN)
      • TABLE 57     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 58     APAC CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 59     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2016-2024) ($MN)
      • TABLE 60     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 61     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 62     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 63     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 64     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 65     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2016-2024) ($MN)
      • TABLE 66     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 67     ROW CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2016-2024) ($MN)
      • TABLE 68     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2016-2024) ($MN)
      • TABLE 69     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 70     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 71     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 72     APPROVALS, (2015-2017)
      • TABLE 73     ACQUISITIONS (2015-2017)
      • TABLE 74     PARTNERSHIPS (2015-2017)
      • TABLE 75     OTHER DEVELOPMENTS (2015-2017)
      • TABLE 76     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 77     ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 78     ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 79     ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 80     ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 81     FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 82     FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 83     FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 84     GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 85     GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
      • TABLE 86     GETINGE GROUPS: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 87     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 88     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 89     MEDTRONIC, PLC: CARDIAC & VASCULAR TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
      • TABLE 90     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 91     TELEFLEX INCORPORATED: TOTAL SALES AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 92     TELEFLEX INCORPORATED: TOTAL SALES, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 93     TELEFLEX INCORPORATED: TOTAL SALES, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 94     ZEON CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 95     ZEON CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 96     ZEON CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: CARDIAC ASSIST DEVICES GLOBAL MARKET
      • FIGURE 3     CARDIAC ASSIST DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CARDIAC ASSIST DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CARDIAC ASSIST DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     CARDIAC ASSIST DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     CARDIAC ASSIST DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2012-2017)
      • FIGURE 9     CARDIAC ASSIST DEVICE GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     CARDIAC ASSIST DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     CARDIAC ASSIST DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 12     VENTRICULAR ASSIST DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 13     INTRA-AORTIC BALLOON PUMP GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 14     EXTRACORPOREAL VENTRICULAR ASSIST DEVICE NUMBER OF UNITS, BY REGION (2017 V/S 2024) (NO’S)
      • FIGURE 15     INTRACORPOREAL VENTRICULAR ASSIST DEVICES NUMBER OF UNITS, BY REGION (2017 V/S 2024) (NO’S)
      • FIGURE 16     PERCUTANEOUS VENTRICULAR ASSIST DEVICES NUMBER OF UNITS, BY REGION (2017 V/S 2024) (NO’S)
      • FIGURE 17     TOTAL ARTIFICIAL HEART NUMBER OF UNITS, BY REGION (2017 V/S 2024) (NO’S)
      • FIGURE 18     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2017 V/S 2024) ($MN)
      • FIGURE 19     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2017 V/S 2024) ($MN)
      • FIGURE 20     VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 21     LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 22     RIGHT VENTRICUALR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION (2017 V/S 2024) (%)
      • FIGURE 23     BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 24     INTRA-AORTIC BALLOON PUMP GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 25     TOTAL ARTIFICIAL HEART GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 26     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 27     EXTRACORPOREAL CAD GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 28     INTRACORPOREAL CAD GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 29     PERCUTANEOUS CAD GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 30     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE (2017 V/S 2024) ($MN)
      • FIGURE 31     PULSATILE FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 32     CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE (2017 V/S 2024) ($MN)
      • FIGURE 33     CONTINUOUS FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 34     CENTRIFUGAL FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 35     AXIAL FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 36     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE (2017 V/S 2024) ($MN)
      • FIGURE 37     PEDIATRIC CAD GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 38     ADULT VAD GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 39     CARDIAC ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2017 V/S 2024) ($MN)
      • FIGURE 40     BRIDGE TO TRANSPLANT GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 41     BRIDGE TO DESTINATION THERAPY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 42     BRIDGE TO RECOVERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 43     CARDIAC ASSIST DEVICE GLOBAL MARKET REVENUE, BY END-USER, (2017 V/S 2024) ($MN)
      • FIGURE 44     HOSPITAL GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 45     ACADEMIC & RESEARCH INSTITUTES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 46     OTHER END-USER GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 47     CARDIAC ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%)
      • FIGURE 48     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 49     NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 50     NORTH AMERICA CARDIAC ASSIST DEVICES REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 51     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2017 V/S 2024) ($MN)
      • FIGURE 52     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2017 V/S 2024) ($MN)
      • FIGURE 53     U.S. CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCTS/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 54     U.S. CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 55     OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 56     OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 57     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 58     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 59     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 60     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2017 V/S 2024) ($MN)
      • FIGURE 61     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2017 V/S 2024) ($MN)
      • FIGURE 62     GERMANY CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 63     GERMANY CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 64     FRANCE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 65     FRANCE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 66     U.K. CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 67     U.K. CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 68     OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 69     OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 70     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 71     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 72     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 73     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2017 V/S 2024) ($MN)
      • FIGURE 74     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2017 V/S 2024) ($MN)
      • FIGURE 75     JAPAN CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 76     JAPAN CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 77     CHINA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 78     CHINA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 79     INDIA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 80     INDIA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 81     OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 82     OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 83     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 84     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS, (2017 V/S 2024) ($MN)
      • FIGURE 85     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 86     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY END-USER, (2017 V/S 2024) ($MN)
      • FIGURE 87     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2017 V/S 2024) ($MN)
      • FIGURE 88     BRAZIL CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 89     BRAZIL CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 90     REST OF LATIN AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 91     REST OF LATIN AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 92     MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 93     MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE/END-USER (2017 V/S 2024) ($MN)
      • FIGURE 94     KEY GROWTH STRATEGIES, (2015-2017)
      • FIGURE 95     APPROVALS BY MAJOR COMPANIES (2017-2024)
      • FIGURE 96     ACQUISITION BY MAJOR COMPANIES (2017-2024)
      • FIGURE 97     OTHER DEVELOPMENTS BY MAJOR COMPANIES (2017-2024)
      • FIGURE 98     SWOT: ABBOTT LABORATORIES
      • FIGURE 99     SWOT: ABIOMED
      • FIGURE 100     SWOT: BERLIN HEART GMBH
      • FIGURE 101     SWOT: BIVACOR INC.
      • FIGURE 102     SWOT: CARMAT SA
      • FIGURE 103     SWOT: FRESENIUS MEDICAL CARE AG & CO. KGAA CARE (XENIOS AG)
      • FIGURE 104     SWOT: GETINGE GROUP (MAQUET)
      • FIGURE 105     SWOT: MEDTRONIC, PLC
      • FIGURE 106     SWOT: RELIANTHEART, INC.
      • FIGURE 107     SWOT: SYNCARDIA SYSTEMS, INC
      • FIGURE 108     SWOT: TELEFLEX INCORPORATED
      • FIGURE 109     SWOT: ZEON CORPORATION

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABBOTT LABORATORIES
      • 2     ABIOMED, INC.
      • 3     BALTON SP. Z O.O
      • 4     BERLIN HEART GMBH
      • 5     BIVACOR, INC.
      • 6     CALON CARDIO -TECHNOLOGY LTD
      • 7     CARDIOBRIDGE GMBH
      • 8     CARMAT SA
      • 9     CLEVELAND HEART, INC.
      • 10     CORWAVE SA
      • 11     EVAHEART, INC.
      • 12     FINEHEART SARL
      • 13     FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
      • 14     GETINGE AB (MAQUET HOLDING)
      • 15     GPB LIFE SCIENCE HOLDINGS LLC (INSIGHTRA MEDICAL, INC.)
      • 16     JARVIK HEART, INC.
      • 17     MEDTRONIC PLC
      • 18     MITIHEART CORPORATION
      • 19     OREGONHEART
      • 20     PROCYRION
      • 21     RELIANTHEART, INC.
      • 22     SCANDINAVIAN REAL HEART
      • 23     SENKO MEDICAL INSTRUMENT MFG. CO., LTD
      • 24     SYNCARDIA SYSTEMS, LLC
      • 25     TANDEM LIFE (CARDIACSYSTEM, INC)
      • 26     TELEFLEX INCORPORATED
      • 27     WINDMILL CARDIOVASCULAR SYSTEMS, INC. (WCS)
      • 28     ZEON CORPORATION